Abviris Overview
- Founded
- 2014
- Status
- Private
- Latest Deal Type
- Series A
- Latest Deal Amount
- $3.38M
- Investors
- 3
Abviris General Information
Description
Developer of an immune-oncology diagnostics designed for early detection of HPV induced cancer. The company addresses the globally increasing problem of cancer caused by the human papillomavirus (HPV) and are dedicated to improve the clinical outcomes of patients and enable clinicians worldwide to fight HPV-induced tumors, including head and neck cancer, penile and anal tumors, vaginal and vulvar cancer and of course cervical cancer, enabling physicians to detect cancer and get results of the examination available within 15 minutes.
Contact Information
Website
Formerly Known As
Abviris Deutschland UG
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
- Beimoorkamp 6
- 22926 Ahrensburg
- Germany
+49 04102 0000000
Abviris Timeline
Abviris Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 26-Jun-2019 | $3.38M | 00.000 | 000.00 | Completed | Generating Revenue |
| 2. Accelerator/Incubator | 01-Apr-2019 | 00.000 | Completed | Generating Revenue | ||
| 1. Seed Round | 21-Jan-2016 | $1.09M | $1.09M | 00.000 | Completed | Generating Revenue |
Abviris Executive Team (4)
Abviris Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| German Accelerator | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
| High-Tech Gründerfonds | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Mittelständische Beteiligungsgesellschaft Schleswig-Holstein | Venture Capital | Minority | 000 0000 | 000000 0 |